CLBS Annual Accounts Receivable
N/A
31 December 2021
Summary:
CLBS annual accounts receivable is not available.CLBS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Quarterly Accounts Receivable
N/A
01 September 2022
Summary:
CLBS quarterly accounts receivable is not available.CLBS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CLBS Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Caladrius Biosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $144.30 K(-64.1%) |
| Sept 2017 | - | $401.60 K(+19.7%) |
| June 2017 | - | $335.60 K(-89.4%) |
| Mar 2017 | - | $3.17 M(+2183.0%) |
| Dec 2016 | $138.80 K(-94.6%) | $138.80 K(-96.8%) |
| Sept 2016 | - | $4.27 M(+47.8%) |
| June 2016 | - | $2.89 M(+10.7%) |
| Mar 2016 | - | $2.61 M(+1.8%) |
| Dec 2015 | $2.57 M(-17.5%) | $2.57 M(+11.6%) |
| Sept 2015 | - | $2.30 M(+77.2%) |
| June 2015 | - | $1.30 M(-34.1%) |
| Mar 2015 | - | $1.97 M(-36.7%) |
| Dec 2014 | $3.11 M(+67.2%) | $3.11 M(+48.9%) |
| Sept 2014 | - | $2.09 M(-16.8%) |
| June 2014 | - | $2.51 M(+33.0%) |
| Mar 2014 | - | $1.89 M(+1.4%) |
| Dec 2013 | $1.86 M(+76.6%) | $1.86 M(+33.4%) |
| Sept 2013 | - | $1.39 M(+98.8%) |
| June 2013 | - | $701.60 K(-20.8%) |
| Mar 2013 | - | $886.20 K(-15.9%) |
| Dec 2012 | $1.05 M(+4.3%) | $1.05 M(-41.3%) |
| Sept 2012 | - | $1.79 M(+42.8%) |
| June 2012 | - | $1.26 M(-88.0%) |
| Mar 2012 | - | $10.44 M(+933.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $1.01 M(-82.8%) | $1.01 M(-88.7%) |
| Sept 2011 | - | $8.94 M(+21.7%) |
| June 2011 | - | $7.35 M(+3.5%) |
| Mar 2011 | - | $7.11 M(+21.0%) |
| Dec 2010 | $5.87 M(+2.6%) | $5.87 M(+29.8%) |
| Sept 2010 | - | $4.52 M(-24.8%) |
| June 2010 | - | $6.01 M(+9.4%) |
| Mar 2010 | - | $5.50 M(-4.0%) |
| Dec 2009 | $5.73 M(>+9900.0%) | $5.73 M(+3397.4%) |
| Sept 2009 | - | $163.70 K(+319.7%) |
| June 2009 | - | $39.00 K(+222.3%) |
| Mar 2009 | - | $12.10 K(+68.1%) |
| Dec 2008 | $7200.00(-70.7%) | $7200.00(-37.4%) |
| Sept 2008 | - | $11.50 K(-63.0%) |
| June 2008 | - | $31.10 K(+15.6%) |
| Mar 2008 | - | $26.90 K(+9.3%) |
| Dec 2007 | $24.60 K(+170.3%) | $24.60 K(-45.9%) |
| Sept 2007 | - | $45.50 K(-1.7%) |
| June 2007 | - | $46.30 K(-3.3%) |
| Mar 2007 | - | $47.90 K(+426.4%) |
| Dec 2006 | $9100.00(+810.0%) | $9100.00(-99.3%) |
| Mar 2002 | - | $1.25 M |
| Mar 1997 | $1000.00(>+9900.0%) | - |
| Mar 1996 | $0.00 | - |
FAQ
- What is the all time high annual accounts receivable for Caladrius Biosciences?
- What is the all time high quarterly accounts receivable for Caladrius Biosciences?
What is the all time high annual accounts receivable for Caladrius Biosciences?
Caladrius Biosciences all-time high annual accounts receivable is $5.87 M
What is the all time high quarterly accounts receivable for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly accounts receivable is $10.44 M